Previously, KRAS testing was performed on tumour tissue, where DNA is extracted from formalin-fixed paraffin-embedded (FFPE) tissue blocks, followed by a variety of polymerase chain reaction (PCR)-based testing methods including sanger sequencing and pyrosequencing. Here, KRAS is linked to neoplasm.